Uncategorized
Blade Exits Air Taxi Space, Sells Unit To Joby To Focus On Medical Logistics
Blade Air Mobility Inc. sells passenger division to Joby Aviation Inc. for $125 million, rebranding as Strata Critical Medical to focus on medical transport and logistics. read more
Tesla Says Retaining Elon Musk Is ‘More Important Than Ever Before’ As Company Kicks Off $29 Billion Compensation Process For CEO (UPDATED)
Tesla Inc. to award CEO Elon Musk with 96 million shares as compensation amid court ruling against $56 billion pay package. read more
Vandalism Against Satoshi Nakamoto Statue Sparks Protest: You Can Steal Our Symbol, But You Will Never Be Able To Steal Our Souls’
Lugano’s landmark tribute to Bitcoin‘s (CRYPTO: BTC) anonymous creator met a violent end this week after the Satoshi Nakamoto statue was found shattered and read more
Demystifying Ocugen: Insights From 5 Analyst Reviews
Latest Ratings for OCGN Date Firm Action From To Feb 2022 HC Wainwright & Co. Maintains Buy Jun 2021 Roth Capital Downgrades Buy Neutral Jun 2021 HC Wainwright & Co. Maintains Buy View More Analyst Ratings for OCGN View the Latest Analyst Ratings read more
UnitedHealth’s Meta Moment? Bleeding Out Or Just A Bad X-Ray?
UnitedHealth has been hit hard, but its fundamentals suggest a market overreaction. Its AI-driven subsidiary Optum Insight is a hidden gem. read more
8 Analysts Assess Arhaus: What You Need To Know
Latest Ratings for ARHS Date Firm Action From To Nov 2021 Barclays Initiates Coverage On Overweight Nov 2021 William Blair Initiates Coverage On Outperform Nov 2021 Morgan Stanley Initiates Coverage On Equal-Weight View More Analyst Ratings for ARHS View the Latest Analyst Ratings read more
Where Axsome Therapeutics Stands With Analysts
Latest Ratings for AXSM Date Firm Action From To Mar 2022 SVB Leerink Maintains Outperform Nov 2021 SVB Leerink Maintains Outperform Aug 2021 HC Wainwright & Co. Maintains Buy View More Analyst Ratings for AXSM View the Latest Analyst Ratings read more
Expert Outlook: Ares Management Through The Eyes Of 6 Analysts
Latest Ratings for ARES Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 UBS Maintains Buy Feb 2022 BMO Capital Maintains Outperform View More Analyst Ratings for ARES View the Latest Analyst Ratings read more